Manufacturer
DUOPHARMA (M) SDN. BHD.
Contents
Ceftazidime pentahydrate
Indication
Complicated urinary tract infections, Bacterial meningitis, Empiric therapy for febrile neutropenic patients, Nosocomial pneumonia, Bone and joint infections, Complicated intra-abdominal infections, Skin and skin structure infections, complicated, Pseudomonal lung infections in cystic fibrosis, Prophylaxis of surgical infection in patients undergoing prostate surgery.
Instruction
Administer via deep IM injection, slow IV.
Drug interaction
May increase nephrotoxicity of aminoglycosides. May diminish therapeutic effect of BCG, typhoid vaccine, Na picosulfate. May increase anticoagulant effect of vit K antagonists (e.g. warfarin). May increase serum level w/ probenecid.
Malaysia
